VEGF Release in Multiluminal Hydrogels Directs Angiogenesis from Adult Vasculature In Vitro

Cardiovascular Engineering and Technology

Volumn 2, Issue 3, 2011, Pages 173-185

  Dawood, A F ^a,b   Lotfi, P ^a,b   Dash, S N ^a,b   Kona, S K ^a,b   Nguyen, K T ^a,b   Romero Ortega, Mario I ^a,b  

^a University of Texas at Arlington   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Microchannels; PLGA; Vascularization; VEGF

Indexed keywords

AGAROSE; ANGIOGENESIS; BIOENGINEERED TISSUE; CO-CULTURES; COLLAGEN MATRICES; CONTROLLED RELEASE; GROWTH FACTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; IMPLANT FAILURES; IMPLANT SURVIVAL; IN-VITRO; INTRALUMINAL; PLGA; POROUS SCAFFOLD; SHARP CONTRAST; THICK-TISSUE; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR NETWORK; VASCULARIZATION; VASCULATURE; VASCULOGENESIS; VEGF; VEGF RELEASE; VESSEL-LIKE STRUCTURES;

ARTIFICIAL ORGANS; BLOOD VESSELS; CELL CULTURE; ENDOTHELIAL CELLS; HISTOLOGY; HYDROGELS; MICROCHANNELS; PEPTIDES; TISSUE;

SCAFFOLDS (BIOLOGY);

AGAROSE; CD31 ANTIGEN; SCAFFOLD PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; BIODEGRADABILITY; BIOENGINEERING; BLOOD VESSEL; COCULTURE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROGEL; IMAGING; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN SECRETION; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING; TWO DIMENSIONAL IMAGING; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

EID: 79960955470     PISSN: 1869408X     EISSN: 18694098     Source Type: Journal    
DOI: 10.1007/s13239-011-0048-4     Document Type: Article

References (55)

1. Asahara, T., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18: 3964-3972, 1999.
2. Au, P., J. Tam, D. Fukumura, and R. K. Jain. Small blood vessel engineering. Methods Mol. Med. 140: 183-195, 2007.
3. Bahramsoltani, M., and J. Plendl. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis. APMIS 115: 30, 2007.
4. Bender, M., J. Bennett, R. Waddell, J. Doctor, and K. Marra. Multi-channeled biodegradable polymer/cultispher composite nerve guides. Biomaterials 25: 1269-1278, 2004.
5. Betsholtz, C., et al. Role of platelet-derived growth factor in mesangium development and vasculopathies: lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice. Curr. Opin. Nephrol. Hypertens. 13: 45, 2004.
6. Cao, Y., et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem. Biophys. Res. Commun. 332: 370-379, 2005.
7. Capla, J. M., et al. Skin graft vascularization involves precisely regulated regression and replacement of endothelial cells through both angiogenesis and vasculogenesis. Plast. Reconstr. Surg. 117: 836-844, 2006.
8. Chen, M., F. Zhang, and W. Lineaweaver. Luminal fillers in nerve conduits for peripheral nerve repair. Ann. Plast. Surg. 57: 462, 2006.
9. Clark, E., and E. Clark. Microscopic observations on the growth of blood capillaries in the living mammal. Am. J. Anat. 64: 251-301, 1939.
10. Dahl, S., C. Rhim, Y. Song, and L. Niklason. Mechanical properties and compositions of tissue engineered and native arteries. Ann. Biomed. Eng. 35: 348-355, 2007.
11. de Ruiter, G., et al. Methods for in vitro characterization of multichannel nerve tubes. J. Biomed. Mater. Res. A 84: 643, 2008.
12. Frelin, C., A. Ladoux, and G. D'Angelo. Vascular endothelial growth factors and angiogenesis. Ann. Endocrinol. (Paris) 61: 70-74, 2000.
13. Gafni, Y., et al. Design of a filamentous polymeric scaffold for in vivo guided angiogenesis. Tissue Eng. 12: 3021-3034, 2006.
14. Godbey, W., B. Stacey Hindy, M. Sherman, and A. Atala. A novel use of centrifugal force for cell seeding into porous scaffolds. Biomaterials 25: 2799-2805, 2004.
15. Hirschi, K., S. Rohovsky, L. Beck, S. Smith, and P. D'Amore. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-bb and heterotypic cell contact. Circ. Res. 84: 298, 1999.
16. Hirschi, K. K., T. C. Skalak, S. M. Peirce, and C. D. Little. Vascular assembly in natural and engineered tissues. Ann. N. Y. Acad. Sci. 961: 223-242, 2002.
17. Hutmacher, D. Scaffold design and fabrication technologies for engineering tissues state of the art and future perspectives. J. Biomater. Sci. Polym. Ed. 12: 107-124, 2001.
18. Invernici, G., et al. Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. Am. J. Pathol. 170: 1879-1892, 2007.
19. Italiano, Jr., J., et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet {alpha} granules and differentially released. Blood 111: 1227, 2008.
20. Iwasaki, K., et al. Bioengineered three-layered robust and elastic artery using hemodynamically-equivalent pulsatile bioreactor. Circulation 118: S52, 2008.
21. Kaihara, S., et al. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng. 6: 105-117, 2000.
22. Kim, B., A. Putnam, T. Kulik, and D. Mooney. Optimizing seeding and culture methods to engineer smooth muscle tissue on biodegradable polymer matrices. Biotechnol. Bioeng. 57: 46-54, 1998.
23. Ko, H. C., B. K. Milthorpe, and C. D. McFarland. Engineering thick tissues-the vascularisation problem. Eur. Cell Mater. 14: 1-18, 2007; discussion 18-9.
24. Konig, G., et al. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 30: 1542-1550, 2009.
25. Kopp, J., M. Jeschke, A. Bach, U. Kneser, and R. Horch. Applied tissue engineering in the closure of severe burns and chronic wounds using cultured human autologous keratinocytes in a natural fibrin matrix. Cell Tissue Banking 5: 81-87, 2004.
26. Larsen, A. Suramin: an anticancer drug with unique biological effects. Cancer Chemother. Pharmacol. 32: 96-98, 1993.
27. Matsusaki, M., H. Sakaguchi, T. Serizawa, and M. Akashi. Controlled release of vascular endothelial growth factor from alginate hydrogels nano-coated with polyelectrolyte multilayer films. J. Biomater. Sci. Polym. Ed. 18: 775-783, 2007.
28. Merks, R. M., S. V. Brodsky, M. S. Goligorksy, S. A. Newman, and J. A. Glazier. Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling. Dev. Biol. 289: 44-54, 2006.
29. Moon, J. H., et al. Isolation and characterization of multipotent human keloid-derived mesenchymal-like stem cells. Stem Cells Dev. 17: 713-724, 2008.
30. Moon, J. J., and J. L. West. Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials. Curr. Top. Med. Chem. 8: 300-310, 2008.
31. Nasseri, B., et al. Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng. 9: 291-299, 2003.
32. Nillesen, S., et al. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 28: 1123-1131, 2007.
33. Norotte, C., F. Marga, L. Niklason, and G. Forgacs. Scaffold-free vascular tissue engineering using bioprinting. Biomaterials 30: 5910-5917, 2009.
34. Patel, Z., H. Ueda, M. Yamamoto, Y. Tabata, and A. Mikos. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm. Res. 25: 2370-2378, 2008.
35. Perea, H., J. Aigner, U. Hopfner, and E. Wintermantel. Direct magnetic tubular cell seeding: A novel approach for vascular tissue engineering. Cells Tissues Organs 183: 156-165, 2006.
36. Pike, D., et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27: 5242-5251, 2006.
37. Priya, S. G., H. Jungvid, and A. Kumar. Skin tissue engineering for tissue repair and regeneration. Tissue Eng. Part B Rev. 14: 105-118, 2008.
38. Roberts, S., D. Howard, L. Buttery, and K. Shakesheff. Clinical applications of musculoskeletal tissue engineering. Br. Med. Bull. 86: 7-22, 2008.
39. Rocha, F., et al. The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials 29: 2884-2890, 2008.
40. Rouwkema, J., N. C. Rivron, and C. A. van Blitterswijk. Vascularization in tissue engineering. Trends Biotechnol. 26(8): 431-441, 2008.
41. Sachlos, E., D. Gotora, and J. Czernuszka. Collagen scaffolds reinforced with biomimetic composite nano-sized carbonate-substituted hydroxyapatite crystals and shaped by rapid prototyping to contain internal microchannels. Tissue Eng. 12: 2479-2487, 2006.
42. Shen, Y. H., M. S. Shoichet, and M. Radisic. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater. 4: 477-489, 2008.
43. Sieminski, A., R. Hebbel, and K. Gooch. The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Exp. Cell Res. 297: 574-584, 2004.
44. Sodian, R., et al. Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering. Tissue Eng. 8: 863-870, 2002.
45. Soker, S., S. Takashima, H. Miao, G. Neufeld, and M. Klagsbrun. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735-746, 1998.
46. Tabata, Y., M. Miyao, M. Ozeki, and Y. Ikada. Controlled release of vascular endothelial growth factor by use of collagen hydrogels. J. Biomater. Sci. Polym. Ed. 11: 915-930, 2000.
47. Tan, W., and T. Desai. Microfluidic patterning of cells in extracellular matrix biopolymers: effects of channel size, cell type, and matrix composition on pattern integrity. Tissue Eng. 9: 255-267, 2003.
48. Vacanti, C. History of tissue engineering and a glimpse into its future. Tissue Eng. 12: 1137-1142, 2006.
49. Wendt, D., A. Marsano, M. Jakob, M. Heberer, and I. Martin. Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnol. Bioeng. 84: 205-214, 2003.
50. Wu, X., et al. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 287: H480-H487, 2004.
51. Yancopoulos, G., et al. Vascular-specific growth factors and blood vessel formation. Nature (London) 407: 242-248, 2000.
52. Yang, T., H. Miyoshi, and N. Ohshima. Novel cell immobilization method utilizing centrifugal force to achieve high-density hepatocyte culture in porous scaffold. J. Biomed. Mater. Res. 55: 379-386, 2001.
53. Yang, K., and A. Proweller. Vascular smooth muscle notch signals regulate endothelial cell sensitivity to angiogenic stimulation. J. Biol. Chem. 286(15): 13741-13753, 2011.
54. Zachary, I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 14: 207-221, 2005.
55. Zengin, E., et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133: 1543-1551, 2006.